冠心病患者分泌型磷脂酶A2的变化及其与高敏C反应蛋白的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


The Changes of Secretory Type Ⅱ Phospholipase A2 in Coronary Heart Disease and Its Relationship with High Sensitive-C Reactive Protein
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的探讨冠心病患者分泌型磷脂酶A2的变化及其与冠心病类型及炎症状态的关系。方法经冠状动脉造影确诊的患者中,急性冠状动脉综合症患者110例,稳定型冠心病患者63例,非冠心病患者89例,采用酶联免疫吸附法测定分泌型磷脂酶A2水平。结果冠心病患者分泌型磷脂酶A2水平与非冠心病患者相比明显升高(55.18±11.75 ku/L比68.15±16.70 ku/L,p<0.01),而急性冠状动脉综合症患者分泌型磷脂酶A2与稳定型冠心病患者相比升高更为显著(62.63±11.92 ku/L比71.32±18.07 ku/L,p<0.01);分泌型磷脂酶A2水平与高敏C反应蛋白呈正相关(p<0.05)。结论冠心病患者分泌型磷脂酶A2浓度明显升高,其水平可能与冠状动脉内的斑块稳定相关,并在一定程度上可反映出冠心病的炎症状态。

    Abstract:

    Aim To study the changes of secretory type Ⅱphospholipase A2(sPLA2) in coronary heart disease(CHD) and the relationship with high sensitive Creactive protein(hs-CRP). Methods According to clinical syndrome and angiography,110 patients were enrolled as acute coronary syndrome(ACS) group,63 patients as stable coronary heart(SCHD) disease(SCHD) group and 89 non-CHD patients as control group.Serum levels of sPLA2 was measured by enzyme linked immunosorbent assay(ELISA) in all subjects and the relationship with hs-CRP was studied. Results Compared with control group,the level of serum sPLA2 was higher in CHD group(55.18±11.75 ku/L vs 68.15±16.70 ku/L,p<0.01),which was also higher in ACS group than that in SCHD group(71.32±18.07 ku/L vs 62.63±11.92 ku/L,p<0.01).The level of serum sPLA2 was positively correlated with hs-CRP. Conclusion The increasing level of serum sPLA2 is correlated with CHD and the stability of coronary plaque.sPLA2 may be one of the important inflammation indicators in patients with coronary artery disease.

    参考文献
    相似文献
    引证文献
引用本文

于路,姜文兵,傅国胜,黄兆铨.冠心病患者分泌型磷脂酶A2的变化及其与高敏C反应蛋白的关系[J].中国动脉硬化杂志,2006,14(10):884~886.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2006-06-08
  • 最后修改日期:2006-10-08
  • 录用日期:
  • 在线发布日期: